Press Releases

Date Title and Summary Additional Formats
Toggle Summary Medidata Opens New, Larger London EMEA Headquarters
Europe /EMEA Experiencing Rapid Growth, Expanded New Facilities to Meet Demand NEW YORK --(BUSINESS WIRE)--Sep. 27, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the official opening of its new EMEA
View HTML
Toggle Summary Medidata to Present at Citi 2017 Global Technology Conference
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Mike Capone , chief operating officer, and Rouven Bergmann , chief financial officer, will present at the Citi 2017 Global
View HTML
Toggle Summary Medidata's Julie Iskow Honored Among PharmaVOICE 100's Most Inspiring People
NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that Julie Iskow , executive vice president and chief technology officer, has been recognized by PharmaVOICE magazine as one of
View HTML
Toggle Summary Fosun Pharma Selects Medidata's Unified Platform for Clinical Development in China
Leading Chinese Healthcare Group Adopts Medidata's Cloud Technology to Bring Operational Efficiencies to its R&D Programs NEW YORK & SHANGHAI --(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced
View HTML
Toggle Summary Medidata Earns Recognition as Leading Innovative Company and a Great Place to Work®
Medidata is named by Forbes as one of the world's most innovative companies and listed as a Great Place to Work by FORTUNE. Medidata is the only company in its space to appear on either list NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology
View HTML
Toggle Summary Medidata Expands Partnership with BeiGene to use Medidata's Patient Cloud ePRO Solution
Expanded Partnership Includes Medidata Patient Cloud ePRO to Seamlessly Collect Patient-Centric Data and Automate Manual Processes for Oncology Research NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical
View HTML
Toggle Summary "Nature Reviews Drug Discovery" Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata
Analysis Drawn from Medidata's PICAS Database Uncovers a Significant Increase in the Number of Distinct Procedures Impacting Both Trial Cost and Site and Patient Burden Drug Development Sponsors Can Use Data to Benchmark Against Organizational Practices and Help Optimize Protocol Design NEW YORK
View HTML
Toggle Summary Medidata Reports Record Second Quarter 2017 Results
Record revenue of $137.4 million , representing 20% year-over-year growth GAAP net income of $8.3 million , or $0.14 per diluted share, up 33% year-over-year Cash flow from operations of $38.2 million , representing 31% year-over-year growth NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the
View HTML
Toggle Summary Medidata Successfully Hosts Annual European NEXT Conference Series
Events Bring Together Industry Leaders to Examine Technology's role in Transforming Clinical Development NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the successful completion of
View HTML
Toggle Summary Worldwide Clinical Trials Selects Medidata to Streamline Clinical Site Reimbursements Across the Globe
Medidata's end-to-end Payments Cloud to help Worldwide change the CRO experience - accelerating accurate, timely payments NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that after
View HTML

Investor Contact

Betsy Frank
Head of Investor Relations
+1 917 522 4620
bfrank@mdsol.com

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com